Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
Drug Discovery: Overview01:26

Drug Discovery: Overview

12.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.2K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

38
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
38
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

54
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Explainable AI Stability with Realistic Synthetic Data for Cardiovascular Risk Prediction.

Studies in health technology and informatics·2026
Same author

Build and Query Indexes of Clinical Documents with Easy-to-Reuse Pipelines.

Studies in health technology and informatics·2026
Same author

Interplay Between Acute Heart Failure and COPD in Patients Hospitalized for Dyspnea: Prognostic Insights From the PARADISE Cohort.

ESC heart failure·2026
Same author

Short- and Long-Term Mortality in Patients Hospitalized for Dyspnoea with Acute Heart Failure, Respiratory Infection, or Both: Insights from the PARADISE Cohort.

European journal of heart failure·2026
Same author

Knowledge graph embedding and alignment of incomplete electronic health records for critical care applications.

Journal of biomedical semantics·2026
Same author

Proteomic phenotyping with machine learning for cardiovascular outcomes in haemodialysis: insights from the AURORA trial.

European heart journal. Digital health·2026

Related Experiment Video

Updated: Feb 24, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Discovering associations between adverse drug events using pattern structures and ontologies.

Gabin Personeni1, Emmanuel Bresso2, Marie-Dominique Devignes2

  • 1LORIA (CNRS, Inria NGE, Université de Lorraine), Campus Scientifique, Vandœuvre-lès-Nancy, F-54506, France. gabin.personeni@loria.fr.

Journal of Biomedical Semantics
|August 24, 2017
PubMed
Summary

This study introduces a novel method using formal concept analysis to uncover patterns in adverse drug events (ADEs) within patient data. The findings reveal frequently associated ADEs in specific patient groups, aiding in better understanding and potential recommendations.

Keywords:
Adverse drug eventAssociation rulesOntologiesPatient dataPattern structuresPharmacovigilance

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K

Related Experiment Videos

Last Updated: Feb 24, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.2K

Area of Science:

  • Computational biology
  • Health informatics
  • Medical data mining

Background:

  • Patient data, including electronic health records and adverse event reporting systems, are crucial for studying Adverse Drug Events (ADEs).
  • Identifying frequently associated ADEs within specific patient subgroups presents a significant challenge in pharmacovigilance.

Purpose of the Study:

  • To explore an original approach for identifying frequently associated ADEs in patient subgroups.
  • To develop a flexible and expressive representation of patient ADEs.

Main Methods:

  • Utilizing formal concept analysis and its pattern structures, a mathematical framework for generalization.
  • Integrating domain knowledge from medical ontologies to enhance analysis.
  • Applying the approach to two distinct datasets across three different settings.

Main Results:

  • Demonstrated the flexibility of the approach in extracting association rules at various levels of generalization.
  • Successfully identified distinct ADEs that co-occur within specific patient groups.
  • Validated the approach's efficacy across multiple datasets and analytical settings.

Conclusions:

  • The proposed method offers an expressive way to represent patient ADEs.
  • Extracted association rules can form the basis for a recommendation system for ADE management.
  • The representation is adaptable and can incorporate additional ontologies and diverse patient records for expanded insights.